Article

ARVO/Alcon early career clinician-scientist research award winners announced

The ARVO Foundation for Eye Research, a supporting non-profit of The Association for Research in Vision and Ophthalmology (ARVO), announced the recipients of the 2007 ARVO/Alcon early career clinician-scientist research awards.

The ARVO Foundation for Eye Research, a supporting non-profit of The Association for Research in Vision and Ophthalmology (ARVO), announced the recipients of the 2007 ARVO/Alcon early career clinician-scientist research awards.

Designed to recognize the importance of clinician-scientists in the ophthalmic research community, the awards are given based on the quality of each recipient's research presented at the ARVO annual meeting. The awardees, who receive grants of $3,000 each, are clinicians with an academic faculty or comparable appointment committed to a career with protected research time. They also work or have previously worked under the guidance of a mentor.

This year's recipients and the abstracts on which the awards are based are:

  • Nitza Goldenberg-Cohen, MD, Schneider Children's Medical Center, Shoham, Israel, "Enhanced neuronal differentiation of bone marrow-derived stem cells in ischemic retina."


  • Andras M. Komaromy, DVM, PhD, University of Pennsylvania School of Veterinary Medicine, Philadelphia, "Cone-directed gene therapy with rAAV leads to restoration of cone function in a canine model of achromatopsia."


  • Rainer A. Leitgeb, PhD, Ecole Polytechnique Federale, Lausanne, Switzerland, "Macular pigment optical density, serum C-reactive protein, and serum lutein and zeaxanthin in age-related maculopathy (ARM)."


  • Malin Malmsjo, MD, PhD, Lund University, Sweden, "Retinal ischemia reperfusion: a new animal model suitable for experimental analysis of the retinal arteries."


  • Takahiro Suzuki, MD, PhD, Tokai University School of Medicine, Ishehara, Japan, "Improvement of pathological neovascularization and astrocyte abnormalities in a mouse model of oxygen-induced retinopathy by augmenting bone marrow-derived endothelial progenitor cell recruitment via link deletion."

Funded by a donation to the foundation from Alcon Laboratories, the awards were presented Sunday during the ARVO/Alcon keynote session.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.